2nd Edition of International Cancer and Precision Oncology Conference

Cancer research continues to advance at an unprecedented pace, creating new opportunities for personalized treatment and improved patient outcomes. The 2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026) (Hybrid Event), scheduled for November 23-25, 2026, in Singapore and Online, will serve as a global meeting point for experts dedicated to accelerating progress in oncology and precision medicine. The Cancer Conference is designed to bring together investigators, physicians, healthcare innovators, pharmaceutical professionals, biotechnology specialists, and academic researchers to discuss ground breaking discoveries influencing contemporary cancer care. Participants will engage in scientific sessions focused on innovative diagnostic tools, molecular profiling, genomic medicine, targeted therapies, immunotherapeutic approaches, and advanced cancer management strategies. Upcoming Oncology Conferences will provide opportunities for presenting original research, exchanging professional experiences, and exploring collaborative solutions to complex challenges in oncology. The scientific agenda will include keynote addresses, expert lectures, research presentations, poster sessions, and interdisciplinary discussions covering a broad spectrum of cancer-related topics. Special emphasis will be placed on precision oncology approaches that integrate genetic, molecular, and clinical data to guide individualized treatment decisions. Emerging technologies, data-driven healthcare models, biomarker-guided therapies, and next-generation therapeutic interventions will also be explored throughout the event. The Precision Oncology Conference format allows participants from across the globe to connect, learn, and collaborate regardless of geographical location. By fostering scientific communication and encouraging multidisciplinary cooperation, ICPOC 2026 aims to support the development of innovative cancer solutions and promote advancements that improve patient care. Researchers, clinicians, healthcare professionals, and industry experts are invited to participate in this influential international conference and contribute to shaping the future of precision oncology.